Royalty Pharma plc — Director's Dealing 2022

Feb 26, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Royalty Pharma plc (RPRX)
CIK: 0001802768
Period of Report: 2022-02-24

Reporting Person: Fernandez Henry A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-24	Class A Ordinary Shares	P	32500	$37.4884	Acquired	58200	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Ordinary Shares	17936	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $37.16 to $37.75. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.